High-risk HPV by PCR/NAAT
Detects DNA or other genetic material from high-risk human papillomavirus types in a cervical or vaginal sample.
HPV, chlamydia, gonorrhoea, HIV, SARS-CoV-2 and serology, with specimen selection based on exposure and method.
HPV, chlamydia, gonorrhoea, HIV, SARS-CoV-2 and serology, with specimen selection based on exposure and method.
Detects DNA or other genetic material from high-risk human papillomavirus types in a cervical or vaginal sample.
Detects genetic material from Chlamydia trachomatis and Neisseria gonorrhoeae at the sampled anatomical site.
The strategy depends on time since exposure: an antigen/antibody test for screening and PCR/NAT for specific indications or very recent exposure.
Detects SARS-CoV-2 genetic material in a respiratory sample compatible with the assay used.
Tests antigens or antibodies for infections such as syphilis, hepatitis B, hepatitis C and HIV, according to the requested profile.
If your question follows unprotected sex, symptoms or uncertainty about the right specimen, use the sexual-health guide before choosing a test.
Open the sexual-health and STI guideEquipment, in-house methods and specialist external referrals.
Open page → How it worksFrom preparation and specimen collection to the final report.
Open page → QualityControl, traceability, review and responsible interpretation.
Open page → CentresAddresses, telephone numbers and contact details for Donostia, Gasteiz and Bilbo.
Open page →